Publication:
Chapter 6: Levan Polysaccharide for Biomedical Applications

dc.contributor.authorsKlrtel O., Öner E.T.
dc.date.accessioned2022-03-15T02:17:18Z
dc.date.accessioned2026-01-10T18:44:02Z
dc.date.available2022-03-15T02:17:18Z
dc.date.issued2021
dc.description.abstractLevan is a homopolysaccharide of fructose units containing β-2,6 linkages between the fructosyl moieties on its backbone with occasional β-2,1 branches, and it is synthesized by a diverse genera of both Gram-positive and Gram-negative bacteria, fungi, some flowering plants, and some halophilic Archaea. With the discovery of its unique physiochemical features such as exceptionally low intrinsic viscosity and high adhesive strength, and bioactive characteristics as an anti-oxidant, anti-carcinogenic, prebiotic, hypoglycemic, and cell-proliferating agent, growing attention toward this polysaccharide has been seen especially in recent years. As a result, levan and its chemically modified derivatives have been the subject of several biomedical applications via development of novel levan-based biomaterials like films, electrospun and 3D-printed scaffolds, and hydrogels. This chapter summarizes the most recent findings from studies that focus on biomedical aspects of levan polysaccharide. © The Royal Society of Chemistry 2021.
dc.identifier.doi10.1039/9781839161124-00134
dc.identifier.issn20487681
dc.identifier.urihttps://hdl.handle.net/11424/248298
dc.language.isoeng
dc.publisherRoyal Society of Chemistry
dc.relation.ispartofRSC Soft Matter
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleChapter 6: Levan Polysaccharide for Biomedical Applications
dc.typebookPart
dspace.entity.typePublication
oaire.citation.endPage154
oaire.citation.issue13
oaire.citation.startPage134
oaire.citation.titleRSC Soft Matter
oaire.citation.volume2021-January

Files